Peter Schäfer

14.7k citations
214 papers · 11.0k · 4 hit papers · h-index 55

Impact in

  • Hematology top 0.2%
    • Multiple Myeloma Research and Treatments
  • Immunology top 1%
    • Immune Cell Function and Interaction

Papers in

    • Protein Degradation and Inhibitors 33
    • Ubiquitin and proteasome pathways 14
    • Multiple Myeloma Research and Treatments 45

Peter Schäfer

203 papers receiving 10.7k citations

Peter Schäfer's Hit Papers

Immunomodulatory agents lenalidomide and pomalidomide co‐stimulate T cells by inducing degradation of T cell repressors I karos and A iolos via modulation of the E 3 ubiquitin ligase complex CRL 4 CRBN 2013 · 463 citations
4630+7+14Years since publication200400600

Peers

Peter Schäfer
Comparison fields: 5 of 151
  • Hematology 2.6k
  • Immunology 2.0k
  • Oncology 2.1k
  • Genetics 780
  • Molecular Biology 4.3k
Replace Anders Waage with:
Anders Waage Norway
Jacqueline Whang‐Peng Taiwan
Hermann-Josef Gröne Germany
Zwi Berneman Belgium
John H. Kersey United States
Giuseppe Leone Italy
Joel S. Greenberger United States
Bayard D. Clarkson United States
Christian Peschel Germany
David R. Spriggs United States
Peter Schäfer relative to Anders Waage Norway Anders Waage's profile →
Citations per field
00.5×1.5×2.3×
Anders Waage · 1×
Citations per year

Countries citing papers authored by Peter Schäfer

Since Specialization
Citations

This map shows the geographic impact of Peter Schäfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Schäfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Schäfer more than expected).

Fields of papers citing papers by Peter Schäfer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Schäfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Schäfer. The network helps show where Peter Schäfer may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Schäfer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Schäfer Line = papers co-authored together Peter Schäfer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 214 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide
Hit paper breakdown →
2012611
2
Keynote review: Phosphodiesterase-4 as a therapeutic target
Hit paper breakdown →
2005525
3
Immunomodulatory agents lenalidomide and pomalidomide co‐stimulate T cells by inducing degradation of T cell repressors I karos and A iolos via modulation of the E 3 ubiquitin ligase complex CRL 4 CRBN
Hit paper breakdown →
2013463
4 2003396
5
Prolonged Bacterial Culture to Identify Late Periprosthetic Joint Infection: A Promising Strategy
Hit paper breakdown →
2008393
6 2008350
7 2012330
8 2008327
9 2014251
10 2005225
11 2017208
12 2007192
13 2008185
14 2014166
15 1998165
16 2008164
17 2009164
18 2003156
19 2006142
20 2010142

About Peter Schäfer

Peter Schäfer is a scholar working on Molecular Biology, Hematology, Oncology, Immunology and Epidemiology, having authored 214 papers that have together received 11.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (45 papers), Protein Degradation and Inhibitors (33 papers), Ubiquitin and proteasome pathways (14 papers), T-cell and B-cell Immunology (11 papers), Cytomegalovirus and herpesvirus research (11 papers), Chronic Lymphocytic Leukemia Research (11 papers), Hepatitis C virus research (10 papers) and Cancer Treatment and Pharmacology (10 papers). The work is most often cited by research in Hematology (2.6k citations), Immunology (2.0k citations), Oncology (2.1k citations), Genetics (780 citations) and Molecular Biology (4.3k citations). Peter Schäfer has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include George W. Muller, David Stirling, Miles D. Houslay, Kam Y. J. Zhang, Rajesh Chopra, J. Blake Bartlett, Bernd Fink, Rainer Laufs, Lei Wu and Anita K. Gandhi. Their work appears in journals such as Blood, Annals of the Rheumatic Diseases, Journal of Clinical Microbiology, Journal of Clinical Oncology and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact